The global continuous glucose monitoring system market size reached USD 4.31 billion in 2020 and is expected to register a revenue CAGR of 19.6% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of diabetes and increasing demand for continuous glucose monitoring systems for better diabetes management are expected to support market revenue growth between 2021 and 2028.Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ [URL]https://www.emergenresearch.com/request-sample/110[/URL]
Besides, increasing usage of continuous glucose monitoring systems during clinical studies will continue to boost revenue growth of the market. According to the National Center for Biotechnology Information, continuous glucose monitoring systems outperform Self-Monitoring Blood Glucose (SMBG) systems in clinical studies including gestational diabetes mellitus.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ [URL]https://www.emergenresearch.com/industry-report/continuous-glucose-monitoring-system-market[/URL]
Some Key Highlights from the Report
Sensor segment is expected to expand at a substantially rapid revenue CAGR during the forecast period as sensor, which employs glucose oxidase to monitor glucose levels, is a key component of continuous glucose monitoring systems.
Adult (>14 years) segment is expected to register a significantly robust revenue growth rate over the forecast period because of the growing geriatric population.
Hospital segment is expected to register a significantly robust revenue growth rate over the forecast period. Growing use of continuous glucose monitoring systems in hospital settings for the detection of blood sugar levels in patients with diabetes mellitus is driving growth of the segment.
Major companies in the market report include Medtronic plc, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Johnson & Johnson Services, Inc., Dexcom, Inc., Echo Therapeutics, Inc., Senseonics Holdings, Inc., A. Menarini Diagnostics Ltd., GlySens Incorporated, and Ypsomed Holding AG
Look Over transcripts provided by Emergen Research
anti-aging devices market: [URL]https://www.emergenresearch.com/industry-report/anti-aging-devices-market[/URL]
industrial packaging market: [URL]https://www.emergenresearch.com/industry-report/industrial-packaging-market[/URL]
business intelligence and analytics market: [URL]https://www.emergenresearch.com/industry-report/business-intelligence-and-analytics-market[/URL]